New XIFIN LIS 8 Helps Diagnostic Laboratories Scale and Respond to Changing Market Dynamics

  • Sep 20, 2021
  • San Diego, CA

New industry research findings inform LIS enhancements, supports digital transformation   San Diego, Calif. – September 20, 2021 – XIFIN, today introduced the newest iteration of its cloud-based laboratory information system (LIS), XIFIN LIS 8, demonstrating the company’s continued investment in improving operational, clinical and financial outcomes for diagnostic providers. New feature...


Leaders from Mayo Clinic Laboratories, Mount Carmel Health System and XIFIN to Explore Strategies to Transform Lab Financial Performance in HFMA Webinar

  • Sep 13, 2021
  • San Diego, CA

Industry experts to share insights for organizational success amid continuing challenges driven by COVID-19 SAN DIEGO, Calif., — September 13, 2021 — In an upcoming Healthcare Financial Management Association (HFMA) member webinar, industry experts Jane Hermansen, Manager, Outreach and Network Development at Mayo Clinic Laboratories, and Emily Adams, Director of Outpatient Laboratory at...


XIFIN Named to the Inc. 5000 List of Fastest-Growing Private Companies in America a 12th Time

  • Aug 17, 2021

Healthcare revenue cycle company experienced 60% revenue growth over three years driven by delivering solutions with high customer impact SAN DIEGO, Calif. – August 17, 2021 - XIFIN today announced it has been named to the Inc. 5000, Inc. Magazine’s annual ranking of the 5,000 fastest-growing private companies in America. During a period of unprecedented challenges for the healthcare industry and...


XIFIN Enters Radiology RCM Services Segment with Computerized Management Services Acquisition

  • Jul 7, 2021

Radiology RCM services deal underscores XIFIN’s commitment to providing the diagnostic health industry with deep expertise, advanced business intelligence and analytics critical for optimizing operations San Diego, Calif. – July 7, 2021 - XIFIN today announced the acquisition of Computerized Management Services (CMS), a provider of revenue cycle management (RCM) services for radiology groups...


XIFIN Establishing Operations in South Carolina

  • Jun 29, 2021

Healthcare revenue cycle company to create more than 150 new jobs over the next two years COLUMBIA, S.C. – XIFIN, a national leader in revenue cycle management (RCM) for diagnostic providers, today announced plans to establish operations in Berkeley County. The company’s new East Coast location will create more than 150 new jobs over the next two years. With over 20 years of experience helping...


XIFIN Executives to Share Insights for Driving 15% Increase in Outpatient and Ancillary Services Profit in Upcoming HFMA Webinar

  • Apr 21, 2021

Recently-promoted COO joins XIFIN CEO and HFMA research lead to discuss how outpatient-specific RCM optimizes operational visibility and revenue versus traditional EHRs. SAN DIEGO, Calif., — April 21, 2021 — In an upcoming Healthcare Financial Management Association (HFMA) member webinar, XIFIN Executive Chairman and CEO Lâle White and Kyle Fetter, recently promoted to chief operating officer at...


XIFIN Innovation Drives Growth in Four Key Business Areas Amid COVID-19 Pandemic

  • Jan 27, 2021

Company executives predict diagnostic volume surge remains through Q1, rise in antibody testing imminent SAN DIEGO, Calif., — January 27, 2021 — Following a year that has redefined the diagnostic laboratory industry and healthcare at large, XIFIN experienced strong growth in four key areas in 2020, with expectations of continued momentum into the new year. This includes expansion into digital...


XIFIN Solutions Recognized by Black Book Research for Four Consecutive Years

  • Nov 10, 2020

Company’s Revenue Cycle Management (RCM) Voted #1 Client Rated Solution by Diagnostic Labs SAN DIEGO, Calif., — November 10, 2020 — 2020 has been a year unlike any other, especially for the healthcare industry. Diagnostic providers, in particular, have faced numerous challenges as they manage a rollercoaster of testing volumes – and associated claims and revenue implications – driven...